Denmark Vaccine Market Size & Outlook, 2026-2033

The vaccine market in Denmark is expected to reach a projected revenue of US$ 557.3 million by 2033. A compound annual growth rate of 6.1% is expected of Denmark vaccine market from 2026 to 2033.
Revenue, 2025 (US$M)
$341.4
Forecast, 2033 (US$M)
$557.3
CAGR, 2026 - 2033
6.1%
Report Coverage
Denmark

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Denmark vaccine market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Denmark vaccine market highlights

  • The Denmark vaccine market generated a revenue of USD 341.4 million in 2025 and is expected to reach USD 557.3 million by 2033.
  • The Denmark market is expected to grow at a CAGR of 6.1% from 2026 to 2033.
  • In terms of segment, viral vaccines was the largest revenue generating indication in 2025.
  • Other Indication is the most lucrative indication segment registering the fastest growth during the forecast period.


Vaccine market data book summary

Market revenue in 2025USD 341.4 million
Market revenue in 2033USD 557.3 million
Growth rate6.1% (CAGR from 2026 to 2033)
Largest segmentViral vaccines
Fastest growing segmentOther Indication
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationViral Vaccines, Bacterial Vaccines, Cancer Vaccines, Allergy Vaccines, Other Indication
Key market players worldwideSerum Institute of India Pvt. Ltd., CSL Ltd, Sanofi SA, GSK PLC, Merck & Co Inc, Pfizer Inc, Sinovac Biotech Ltd, BioNTech SE ADR, AstraZeneca PLC, Moderna Inc


Other key industry trends

  • In terms of revenue, Denmark accounted for 0.5% of the global vaccine market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Europe, Germany vaccine market is projected to lead the regional market in terms of revenue in 2033.
  • France is the fastest growing regional market in Europe and is projected to reach USD 3,784.9 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Vaccine Market Scope

Vaccine market segmentation & scope

Vaccine Market Companies

Name Profile # Employees HQ Website
Moderna Inc View profile 5600 200 Technology Square, Cambridge, MA, United States, 02139 https://www.modernatx.com
BioNTech SE ADR View profile 6133 An der Goldgrube 12, Mainz, RP, Germany, D-55131 https://www.biontech.de
CSL Ltd View profile 32000 655 Elizabeth Street, Melbourne, VIC, Australia, 3000 https://www.csl.com
Sinovac Biotech Ltd View profile 3261 No.39, Shangdi Xi Road, Haidan District, Beijing, China, People's Republic of, 100085 http://www.sinovac.com
AstraZeneca PLC View profile 89900 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA https://www.astrazeneca.com
Serum Institute of India Pvt. Ltd. View profile 1001-5000 Pune, Maharashtra, India, Asia http://www.seruminstitute.com/
GSK PLC View profile 70200 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS https://www.gsk.com
Merck & Co Inc View profile 72000 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 https://www.merck.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com

Denmark vaccine market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to vaccine market will help companies and investors design strategic landscapes.


Viral vaccines was the largest segment with a revenue share of 65.03% in 2025. Horizon Databook has segmented the Denmark vaccine market based on viral vaccines, bacterial vaccines, cancer vaccines, allergy vaccines, other indication covering the revenue growth of each sub-segment from 2021 to 2033.


The Denmark vaccine market is driven by factors such as the presence of well-established healthcare infrastructure, high disease burden, and growing demand for vaccines to manage the disease burden. Moreover, supportive government legislation for vaccination is expected to promote vaccine uptake in the country.

For instance, in August 2021, the Danish Health Authority recommended that children up to 6 years should be vaccinated against the flu. The authority further added that by doing so, the infection rates can be slowed down.

In addition, in December 2022, the vaccination figures were released by the Danish Health Authority, and over 1.5 million people in the country were vaccinated against influenza. Thus, the supportive government legislation is fueling vaccine uptake in the country, thereby fueling market growth.

Reasons to subscribe to Denmark vaccine market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Denmark vaccine market databook

  • Our clientele includes a mix of vaccine market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Denmark vaccine market , including forecasts for subscribers. This country databook contains high-level insights into Denmark vaccine market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Denmark Recombinant Vaccines - Vaccine Market, 2024 - 2030 (US$M)

Denmark Vaccine Market Outlook Share, 2025 & 2033 (US$M)

Denmark Recombinant Vaccines - Vaccine Market, 2024 - 2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online